Serological Assays for the Detection and Characterization of Influenza Viruses
Health and Human Services, Department of · CENTERS FOR DISEASE CONTROL AND PREVENTION
This notice is not accepting responses (deadline was May 6, 2025, 8:00 PM EDT).
Page kept for research and related open opportunities below. For current work in this category, use the related notices or browse hubs.
- Response deadline
- May 6, 2025, 8:00 PM EDT
- Posted
- Feb 18, 2025
- Solicitation
- 75D30125R73235
- Set-aside
- None listed
- Place of performance
- Atlanta, GA, USA
- Contracting office
- CDC OFFICE OF ACQUISITION SERVICES · ATLANTA · GA
- Source
- SAM.gov · updated May 9, 2026
Description
Amendment 1 is being issued to push back the due dates for Phase I and Phase II. A PDF copy of the amendment is attached as well as a Word version showing the track changes to the document. The objective of this contract is to support the Influenza Division through the testing of human sera via hemagglutination inhibition assay as well as develop a new serology platform that is comparable to hemagglutination inhibition assay. This is Phase I of a a two phased multi-step mandatory down select solicitation. Interest for Phase I is due to the contracting officer no later than 2:00 PM EST February 21, 2025. The steps in Phase I are as follows: Letter of Interest � offerors shall email POC information to Contracting Officer Proficiency panel will be sent by CDC to intersted offerors Vendor shall email results to CDC Contracting Officer CDC Contractng Officer will notify each offeror of their pass/fail status for Phase I and if they are then able to proceed to Phase II
What similar awards have paid
Real federal awards already on the books in a similar lane — so you can size the opportunity, not guess. This is public history, not a bid price, cost estimate, or prediction that you will win.
Typical award size
$94,574
Middle of the pack for similar past awards
Most similar awards fall between $10,970 and $204,481
Who has won work like this
Public awardees in this lane — useful for competitor scan or teaming ideas, not a ranked list of “best” firms.
- 1CYTOPATH BIOPSY LAB INC1 award$900,000
- 2DIASORIN INC1 award$283,947
- 3CAREDX, INC.1 award$241,464
- 4RADIOMETER AMERICA, INC.1 award$210,328
- 5POLYMEDCO LLC1 award$198,634
- 6ROCHE DIAGNOSTICS CORPORATION1 award$143,354
- 7HELENA LABORATORIES CORPORATION1 award$126,252
- 8POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC2 awards$116,878
Recent examples
A few of the newest similar awards in our index.
- ROCHE DIAGNOSTICS CORPORATIONSep 17, 2025Department of Health and Human Services$143,354Source
- OLINK PROTEOMICS ABSep 17, 2025Department of Health and Human Services$48,240Source
- POLYMEDCO LLCSep 2, 2025Department of Veterans Affairs$198,634Source
- POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLCJun 11, 2025Department of Veterans Affairs$22,304Source
- HELENA LABORATORIES CORPORATIONMay 28, 2025Department of Veterans Affairs$126,252Source
- RADIOMETER AMERICA, INC.May 20, 2025Department of Veterans Affairs$210,328Source
Drawn from official USAspending contract records in our index. Always confirm requirements on the SAM.gov notice before you bid.
Intelligence only — not legal advice or a guarantee of award. Always verify requirements on the official SAM.gov notice. Past award amounts are public history, not a suggested bid or prediction. Notice ID 742fa6578c864e11a0da51d8dbf3d98e.